Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CBST and BIA Separations Cooperate on Purification of Biomolecules

Published: Friday, September 21, 2012
Last Updated: Thursday, September 20, 2012
Bookmark and Share
Both Companies have signed a memorandum of understanding and entered into an agreement.

Centre for Bio Separations Technology (CBST)/VIT University and BIA Separations have announced that they have signed a Memorandum of Understanding on 31st August 2012 and entered into an agreement to cooperate and to work together towards:
• developing innovative bioseparation platforms and technologies,

• education and training of students to prepare them for working in biopharmaceutical industry

• providing technical support, contract research and services to the biopharmaceutical industry, through the setting up of a BIA Separations Platform of Excellence at CBST.

From CBST/VIT perspective, teaming up with BIA Separations will give CBST/VIT access to a unique and leading edge technologies and know-how in the field of downstream purification and separations of large bio-molecules.

Combining this technology and know-how with CBST/VIT excellence in "oriented research" and excellent scientific base, provide opportunities for bridging the gap between industry and academia, in the areas of bioseparations.

BIA Separations recognizes CBST/VIT academic and bioseparation excellence.

Therefore from BIA Separations perspective this partnership is very important for a successful implementation of BIA Separations technologies that would bring benefits to the biopharmaceutical industry and academic research not only in India but worldwide.

This partnership is also in-line with BIA Separations plans to establish BIA Separations India.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!